3115 patient outcomes. Meanwhile, clinicians should keep in mind that result from ASC is only another piece of the puzzle, and it is imperative to take into account other patient-specific risk factors for MRSA when formulating empiric antimicrobial therapy.The authors have not disclosed any potential conflicts of interest.